Switzerland's Drug Pricing Debate
Price increases won't affect existing drugs.
Switzerland's pharmaceutical industry contributes 4 billion Swiss francs annually.
Roche would invest less in research and create fewer jobs without price reforms.
Roche plans $50 billion U.S. investment over five years to counter tariffs.
4 weeks ago